Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Baird Medical Investment ...

    NASDAQ: BDMD · Real-Time Price · USD
    5.42
    1.11 (25.75%)
    At close: Jun 13, 2025, 3:59 PM
    5.52
    1.84%
    After-hours: Jun 13, 2025, 05:43 PM EDT

    Baird Medical Investment Statistics

    Share Statistics

    Baird Medical Investment has 35.73M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 35.73M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,115

    FTD / Avg. Volume

    n/a
    		 2.7%

    Short Selling Information

    The latest short interest is 37.75K, so 0.1% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 37.75K

    Short % of Shares Out

    n/a
    		 0.1%

    Short % of Float

    n/a
    		 0.28%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is 7.7 and the forward PE ratio is null. Baird Medical Investment's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 7.7

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 2.58

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.27

    P/FCF Ratio

    n/a
    		 -22.2

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Baird Medical Investment has an Enterprise Value (EV) of 91.22M.

    EV / Sales

    n/a
    		 2.9

    EV / EBITDA

    n/a
    		 7.1

    EV / EBIT

    n/a
    		 -89.44

    EV / FCF

    n/a
    		 -24.94

    Financial Position

    The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.32.

    Current Ratio

    n/a
    		 2.11

    Quick Ratio

    n/a
    		 2.05

    Debt / Equity

    n/a
    		 0.32

    Debt / EBITDA

    n/a
    		 0.9

    Debt / FCF

    n/a
    		 -3.15

    Interest Coverage

    n/a
    		 41.5

    Financial Efficiency

    Return on Equity is 29.5% and Return on Invested Capital is 21.66%.

    Return on Equity

    n/a
    		 29.5%

    Return on Assets

    n/a
    		 18.6%

    Return on Invested Capital

    n/a
    		 21.66%

    Revenue Per Employee

    n/a
    		 $212,553.43

    Profits Per Employee

    n/a
    		 $71,256.61

    Employee Count

    n/a
    		 148

    Asset Turnover

    n/a
    		 0.55

    Inventory Turnover

    n/a
    		 3.7

    Taxes

    Income Tax

    n/a
    		 1.7M

    Effective Tax Rate

    n/a
    		 13.76%

    Stock Price Statistics

    The stock price has increased by -51.08% in the last 52 weeks. The beta is -0.93, so Baird Medical Investment's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.93

    52-Week Price Change

    n/a
    		 -51.08%

    50-Day Moving Average

    n/a
    		 5.15

    200-Day Moving Average

    n/a
    		 5.39

    Relative Strength Index (RSI)

    n/a
    		 58.68

    Average Volume (20 Days)

    n/a
    		 41,320

    Income Statement

    In the last 12 months, Baird Medical Investment had revenue of 31.46M and earned 10.55M in profits. Earnings per share was -0.22.

    Revenue

    n/a
    		 31.46M

    Gross Profit

    n/a
    		 27.23M

    Operating Income

    n/a
    		 11.86M

    Net Income

    n/a
    		 10.55M

    EBITDA

    n/a
    		 12.85M

    EBIT

    n/a
    		 11.86M

    Earnings Per Share (EPS)

    n/a
    		 -0.22
    Full Income Statement

    Balance Sheet

    The company has 1.51M in cash and 11.51M in debt, giving a net cash position of -10M.

    Cash & Cash Equivalents

    n/a
    		 1.51M

    Total Debt

    n/a
    		 11.51M

    Net Cash

    n/a
    		 -10M

    Retained Earnings

    n/a
    		 14.39M

    Total Assets

    n/a
    		 63M

    Working Capital

    n/a
    		 24.58M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -1.02M and capital expenditures -2.64M, giving a free cash flow of -3.66M.

    Operating Cash Flow

    n/a
    		 -1.02M

    Capital Expenditures

    n/a
    		 -2.64M

    Free Cash Flow

    n/a
    		 -3.66M

    FCF Per Share

    n/a
    		 -0.48
    Full Cash Flow Statement

    Margins

    Gross margin is 86.56%, with operating and profit margins of 37.71% and 33.52%.

    Gross Margin

    n/a
    		 86.56%

    Operating Margin

    n/a
    		 37.71%

    Pretax Margin

    n/a
    		 39.29%

    Profit Margin

    n/a
    		 33.52%

    EBITDA Margin

    n/a
    		 40.86%

    EBIT Margin

    n/a
    		 37.71%

    FCF Margin

    n/a
    		 -11.63%

    Dividends & Yields

    BDMD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 12.98%

    FCF Yield

    n/a
    		 -4.5%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for BDMD.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 12.14

    Graham Upside

    n/a
    		 123.99%

    Scores

    Altman Z-Score

    n/a
    		 5.26

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist